Literature DB >> 90061

Stimulation of neutrophil oxygen-dependent metabolism by human leukocytic pyrogen.

M S Klempner, C A Dinarello, W R Henderson, J I Gallin.   

Abstract

The ability of highly purified human leukocytic pyrogen (LP) to stimulate neutrophil oxygen-dependent metabolism was studied. Human peripheral blood neutrophils exposed to leukocytic pyrogen in vitro demonstrated an increase in the percentage of neutrophils reducing nitroblue tetrazolium (NBT) dye and a marked stimulation of superoxide dismutase inhibitable reduction of ferricytochrome c. LP stimulation of neutrophil oxygen-dependent metabolism was dose and time dependent. Procedures that destroyed the pyrogenicity of LP also abolished the effects on neutrophil metabolism. Neutrophil hexose monophosphate shunt activity was also stimulated by LP. In a rabbit model, the effect of in vivo LP on neutrophil superoxide generation was also studied. There was a consistent increase in the percent and absolute number of NBT positive neutrophils. Peak stimulation of neutrophil metabolism occurred after defervescence suggesting several possible mechanisms. The observations reported here may, in part, explain the nonspecificity of the NBT test in febrile, noninfected patients and provide further understanding of neutrophil physiology during acute inflammation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 90061      PMCID: PMC372208          DOI: 10.1172/JCI109566

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Quantitative aspects of the production of superoxide radicals by phagocytizing human granulocytes.

Authors:  R S Weening; R Wever; D Roos
Journal:  J Lab Clin Med       Date:  1975-02

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  An appraisal of the nitroblue tetrazolium reduction test.

Authors:  J K Lace; J S Tan; C Watanakunakorn
Journal:  Am J Med       Date:  1975-05       Impact factor: 4.965

4.  Human leukocytic pyrogen: purification and development of a radioimmunoassay.

Authors:  C A Dinarello; L Renfer; S M Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

5.  Positive N.B.T. test in acute viral hepatitis.

Authors:  K B Hellum; C O Solberg
Journal:  Lancet       Date:  1973-05-26       Impact factor: 79.321

6.  N.B.T. test in parasitic disease.

Authors:  J H Chretien; V F Garagusi
Journal:  Lancet       Date:  1971-09-04       Impact factor: 79.321

7.  Nitroblue tetrazolium dye test: a diagnostic aid in tuberculosis.

Authors:  G L Mandell; L F Fuller
Journal:  Am Rev Respir Dis       Date:  1972-01

8.  Enhancement of nitroblue tetrazolium dye reduction by leukocytes exposed to a component of complement in the absence of phagocytosis.

Authors:  I M Goldstein; F Feit; G Weissmann
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

9.  Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors.

Authors:  E J Goetzl; K F Austen
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

10.  Reduced nicotinamide adenine dinucleotide and reduced nicotinamide adenine dinucleotide phosphate diaphorase activity in human polymorphonuclear leukocytes.

Authors:  L R DeChatelet; L C McPhail; D Mullikin; C E McCall
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

View more
  34 in total

1.  Physiological studies with human leukocyte inhibitory factor.

Authors:  L C Borish; R E Rocklin
Journal:  Surv Immunol Res       Date:  1985

2.  Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

Review 3.  Secretory products of macrophages.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

4.  Neutrophil stimulation by recombinant cytokines and a factor produced by IL-1-treated human synovial cell cultures.

Authors:  M L Watson; G P Lewis; J Westwick
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

5.  Clinical, hematologic, and immunologic effects of interleukin-10 in humans.

Authors:  A C Fuchs; E V Granowitz; L Shapiro; E Vannier; G Lonnemann; J B Angel; J S Kennedy; A R Rabson; E Radwanski; M B Affrime; D L Cutler; P C Grint; C A Dinarello
Journal:  J Clin Immunol       Date:  1996-09       Impact factor: 8.317

6.  Augmentation of host resistance to microbial infections by recombinant human interleukin-1 alpha.

Authors:  A Minami; K Fujimoto; Y Ozaki; S Nakamura
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

7.  Provocation of pulmonary vascular endothelial injury in rabbits by human recombinant interleukin-1 beta.

Authors:  S E Goldblum; K Yoneda; D A Cohen; C J McClain
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

8.  Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha.

Authors:  B Meier; H H Radeke; S Selle; M Younes; H Sies; K Resch; G G Habermehl
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

9.  Effects of a phagocytosis-stimulating factor on the phagocytic process of polymorphonuclear neutrophils.

Authors:  Y Ishibashi; T Yamashita
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

10.  Activities of superoxide dismutases and NADPH oxidase in neutrophils obtained from asthmatic and normal donors.

Authors:  B Z Joseph; J M Routes; L Borish
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.